Search Results - "Sninska, Zuzana"
-
1
Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic ITP in routine clinical practice in central and Eastern Europe: an analysis of the PLATON study
Published in Hematology (Luxembourg) (01-01-2021)“…The objective of this analysis was to assess the effectiveness and safety of romiplostim in the real-world by duration of primary immune thrombocytopenia…”
Get full text
Journal Article -
2
Evaluation of 5‐year imatinib treatment of 458 patients with CP‐CML in routine clinical practice and prognostic impact of different BCR‐ABL cutoff levels
Published in Cancer medicine (Malden, MA) (01-04-2013)“…We evaluated responses to the treatment and long‐term outcomes of chronic myeloid leukemia patients treated with imatinib as first‐line treatment in routine…”
Get full text
Journal Article -
3
Treatment Outcomes in Patients Treated with Tyrosine Kinase Inhibitors in "Slovak Registry of Chronic Myeloid Leukemia" (CAMELIA SK)
Published in Blood (02-12-2016)“…Introduction: With the onset of tyrosine kinase inhibitors (TKI) to treat patients with CML, the number of patients and overall survival increased and quality…”
Get full text
Journal Article -
4
PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia: An observational, nonintervention study of real-life practice
Published in Memo - Magazine of European medical oncology (01-06-2020)“…Summary Chronic primary immune thrombocytopenia (ITP) is an autoimmune disease involving the formation of antibodies to thrombocytes, leading to increased…”
Get full text
Journal Article -
5
Treatment and Outcome Analysis of 2,904 Pateints from the EUTOS Population Based Registry
Published in Blood (03-12-2015)“…Introduction Clinical studies clearly show that treatment with tyrosine-kinase inhibitors (TKI) greatly improve the prognosis of patients with CML. Detailed…”
Get full text
Journal Article